TABLE 3.
Summary of studies exploring the relationship between the levels of IGF-1 and IS.
References | Race | Case | Control | Sample size | Origin | |||
|
|
|
||||||
Mean | SD | Mean | SD | Case | Control | |||
Schwab et al. (1997) | No mentioned | 105.00 | 23.00 | 161.00 | 10.00 | 20 | 8 | Plasma |
Kaplan et al. (2007) | African-American | 150.30 | 58.30 | 152.20 | 58.30 | 370 | 1,122 | Plasma |
Wang Y. et al. (2014) | China | 122.32 | 86.60 | 77.60 | 53.15 | 79 | 75 | Plasma |
Denti et al. (2004) | Italy | 69.00 | 45.00 | 102.00 | 67.00 | 85 | 88 | Serum |
Johnsen et al. (2005) | Danish | 107.10 | 33.30 | 112.90 | 33.20 | 254 | 254 | Serum |
Aberg et al. (2011) | Western Sweden | 171.00 | 3.30 | 145.40 | 9.40 | 407 | 40 | Serum |
Iso et al. (2012) | Japan | 113.00 | 52.00 | 106.00 | 48.00 | 71 | 71 | Serum |
Dong et al. (2014) | China | 130.40 | 32.80 | 141.40 | 25.40 | 240 | 200 | Serum |
Wang T. et al. (2014) | China | 107.16 | 18.03 | 122.79 | 15.55 | 124 | 96 | Serum |
Shaheen et al. (2018) | Arab | 143.40 | 12.60 | 156.00 | 11.20 | 200 | 100 | Serum |
Zhang W. et al. (2018) | China | 115.50 | 37.30 | 158.50 | 27.80 | 225 | 120 | Serum |